Literature DB >> 15986138

Protein kinase C in melanoma.

Masahiro Oka1, Ushio Kikkawa.   

Abstract

Protein kinase C (PKC) is activated by diacylglycerol generated by receptor-mediated hydrolysis of membrane phospholipids to mediate signals for cell growth and plays as a target of tumor-promoting phorbol esters in malignant transformation. PKC is a family of enzymes and their expression profiles have been examined in the normal melanocytes and melanoma cells, and studies have been carried out on the functions of PKC isoforms in proliferation, transformation, and metastasis of melanoma cells. Here, we summarize current knowledge of the expression and possible roles of the PKC family in melanoma in comparison with those of normal melanocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986138     DOI: 10.1007/s10555-005-1578-8

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  22 in total

1.  Mass-tag technology responding to intracellular signals as a novel assay system for the diagnosis of tumor.

Authors:  Jeong-Hun Kang; Yoshiki Katayama; Aishan Han; Shuhei Shigaki; Jun Oishi; Kenji Kawamura; Riki Toita; Xiao Ming Han; Takeshi Mori; Takuro Niidome
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-13       Impact factor: 3.109

2.  RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.

Authors:  Xu Chen; Qiuxia Wu; Philippe Depeille; Peirong Chen; Sophie Thornton; Helen Kalirai; Sarah E Coupland; Jeroen P Roose; Boris C Bastian
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

3.  From melanocyte to metastatic malignant melanoma.

Authors:  Bizhan Bandarchi; Linglei Ma; Roya Navab; Arun Seth; Golnar Rasty
Journal:  Dermatol Res Pract       Date:  2010-08-11

4.  Rewired ERK-JNK signaling pathways in melanoma.

Authors:  Pablo Lopez-Bergami; Conway Huang; James S Goydos; Dana Yip; Menashe Bar-Eli; Meenhard Herlyn; Keiran S M Smalley; Alka Mahale; Alexey Eroshkin; Stuart Aaronson; Ze'ev Ronai
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

5.  Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma.

Authors:  Samudra K Dissanayake; Ashani T Weeraratna
Journal:  Methods Mol Biol       Date:  2008

6.  12-O-tetradecanoylphorbol-13-acetate inhibits melanoma growth by inactivation of STAT3 through protein kinase C-activated tyrosine phosphatase(s).

Authors:  Masahiro Oka; Naoko Sumita; Masanobu Sakaguchi; Tetsushi Iwasaki; Toshinori Bito; Toshiro Kageshita; Ken-ichi Sato; Yasuo Fukami; Chikako Nishigori
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

7.  Dynamic adhesions and MARCKS in melanoma cells.

Authors:  Adriana Estrada-Bernal; Jesse C Gatlin; Somkiat Sunpaweravong; Karl H Pfenninger
Journal:  J Cell Sci       Date:  2009-06-09       Impact factor: 5.285

8.  Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.

Authors:  Florence R Depontieu; Jie Qian; Angela L Zarling; Tracee L McMiller; Theresa M Salay; Andrew Norris; A Michelle English; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Suzanne L Topalian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

9.  The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2.

Authors:  Masanobu Tsubaki; Hiroshi Matsuoka; Chikako Yamamoto; Chisato Kato; Mitsuhiko Ogaki; Takao Satou; Tatsuki Itoh; Takashi Kusunoki; Yoshihiro Tanimori; Shozo Nishida
Journal:  Clin Exp Metastasis       Date:  2007-07-18       Impact factor: 5.150

10.  The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.

Authors:  Samudra K Dissanayake; Michael Wade; Carrie E Johnson; Michael P O'Connell; Poloko D Leotlela; Amanda D French; Kavita V Shah; Kyle J Hewitt; Devin T Rosenthal; Fred E Indig; Yuan Jiang; Brian J Nickoloff; Dennis D Taub; Jeffrey M Trent; Randall T Moon; Michael Bittner; Ashani T Weeraratna
Journal:  J Biol Chem       Date:  2007-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.